eli lilly news - Search News

Lilly weight-loss drug copycats dealt blow

Yahoo Finance on MSN · 5h

What end of Eli Lilly's weight-loss drug shortage means for the competition

The US Food and Drug Administration confirmed Thursday that Eli Lilly (LLY) has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.

Barron's on MSN · 1d

Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

The Washington Post · 1d

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

Eli Lilly investing $4.5 billion more into LEAP district

FiercePharma · 2d

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of powerhouse rival Johnson & Johnson largely thanks to its diabetes and weight loss franchise—the Indianapolis company has poured much of its revenue into new investment.

Zacks.com on MSN · 1d

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

Eli Lilly and Company LLY announced a significant $4.5 billion investment for the establishment of the Lilly Medicine Foundry in Indiana to advance drug production and innovation. This facility will enable the development of new methods for making its drugs and also scale up the supply of medicines for clinical trials for Lilly’s growing pipeline.

Eli Lilly investing $4.5 billion more into the LEAP district; residents question IEDC's transparency

The company’s first two investments in the district were for a manufacturing site. The new site will focus on research, but some residents feel the IEDC has not been transparent about the project.

40m

Eli Lilly & Co. stock rises Friday, still underperforms market

Eli Lilly & Co. closed $85.37 below its 52-week high ($972.53), which the company reached on August 22nd.

6h

England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access

NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to ...

GlobalData on MSN5h

NHS proposes phased launch for Eli Lilly’s Mounjaro

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Texas AG Ken Paxton Sues Eli Lilly and Major PBMs, Alleging Insulin Price Gouging Conspiracy

Texas is suing insulin manufacturers and PBMs, including Eli Lilly and CVS Pharmacy, alleging a scheme to hike insulin prices ...

6h

Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

NHS England proposes phased rollout for Eli Lilly's star obesity drug

While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...

1d

Eli Lilly & Co (LLY) Gets a Buy from Truist Financial

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Eli Lilly & Co (LLY – Research ...

2d

Lilly to invest $4.5 bln on new Indiana facility

U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results